Development of a novel, low-cost, transdermal drug delivery patch with enhanced API stabilisation

Amphase正在开发一种新颖且多功能的透皮贴片，可用于从缓解疼痛到慢性皮肤疾病的多种应用。其专利技术使活性药物成分能够在不需要有害防腐剂的情况下长期稳定，一旦被用户激活，将通过一系列创新的材料科学和化学事件促进更深层次和更有效地进入皮肤。该公司在原型开发阶段聘请了经验丰富的工业设计师，与化学配方并行工作，研究和创造解决方案，从第一次使用到处置，增强整个用户体验。在患有慢性病的老龄化人口中，最大限度地方便使用自我护理以实现药物依从性带来了许多挑战，尤其是机动性、灵活性、力量、单手应用、移除和安全处置。其目的是重新审视自我给药疗法，在这些疗法中，使用的易用性和简单性将显著有助于市场成功的可能性。

Amaphase is developing a novel and versatile transdermal patch for use across multiple applications from pain relief to chronic skin conditions. Its patented technology allows Active Pharmaceutical Ingredients to be stabilised for long periods without the need for harmful preservatives and, once activated by the user, will facilitate deeper and more efficient delivery into the skin through an innovative sequence of materials science and chemistry-based events. The company has employed experienced industrial designers throughout the prototype development phase to work in parallel with the formulation of the chemistry to investigate and create solutions which enhance the whole user experience from first use to disposal. Maximising ease of use for self-care to achieve medicines adherence in an ageing population with chronic conditions poses a number of challenges, not least mobility, dexterity, strength, single handed application, removal and safe disposal. The aim is to take a fresh look at self-administered treatments where ease and simplicity of use will significantly contribute to the likelihood of market success.